[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580686":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":120,"collaborators":10,"id":122,"slug":123,"hasResults":124,"nctId":125,"briefTitle":126,"officialTitle":126,"acronym":127,"eligibilityCriteria":128,"healthyVolunteers":124,"sex":129,"minAge":130,"maxAge":10,"enrollmentInfo":131,"targetDuration":10,"studyType":134,"phases":10,"briefSummary":135,"conditions":136,"keywords":138,"overallStatus":141,"whyStopped":10,"lastUpdateSubmitDate":142,"lastUpdatePostDateStruct":143,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":151},{"fullName":5,"class":6},"Chiesi Hungary Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Asthma patients on GINA steps 3 and 4 receiving Foster Nexthaler treatment",null,"Asthma patients above the age of 18 years. Uncontrolled according to the physician's clinical assessment despite the use of appropriate therapy of Step 2 or 3, according to GINA guidelines. Patients who are eligible for the use of Foster Nexthaler 100\u002F6 mcg according to the SmPC. Inhaled asthma therapy was changed independent from the study to Foster Nexthaler 100\u002F6 mcg DPI maximum 1 week prior to OR on the day of study inclusion. Spirometry was performed as part of routine clinical practice\n\n. Patient able to use their Foster Nexthaler device properly after education on inhaler technique. Patient provided written, informed consent to study participation",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Balázs Sánta","CONTACT","+36309948432","b.santa@chiesi.com",[19,46,58,73,86,101],{"facility":20,"status":10,"city":21,"state":10,"zip":10,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"National Korányi Institute of Pulmonology","Budapest","Hungary","HU",{"type":25,"coordinates":26},"Point",[27,28],19.04045,47.49835,{"lat":28,"lon":27},[31,33,36,38,40,42,44],{"name":32,"role":15,"phone":10,"phoneExt":10,"email":10},"Ildikó Horváth, Prof.",{"name":34,"role":35,"phone":10,"phoneExt":10,"email":10},"Lilla Horváth, Dr.","SUB_INVESTIGATOR",{"name":37,"role":35,"phone":10,"phoneExt":10,"email":10},"Balázs Juhász, Dr.",{"name":32,"role":39,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":41,"role":35,"phone":10,"phoneExt":10,"email":10},"Péter Somogyi, Dr.",{"name":43,"role":35,"phone":10,"phoneExt":10,"email":10},"Barbara Tamás, Dr.",{"name":45,"role":35,"phone":10,"phoneExt":10,"email":10},"Kincső Marton, Dr.",{"facility":47,"status":10,"city":48,"state":10,"zip":10,"country":22,"countryCode":23,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"Department of Pulmonology and Allergology, Csornai MArgit Hospital","Csorna",{"type":25,"coordinates":50},[51,52],17.25012,47.61155,{"lat":52,"lon":51},[55,57],{"name":56,"role":15,"phone":10,"phoneExt":10,"email":10},"Zoltán Bártfai, Dr.",{"name":56,"role":39,"phone":10,"phoneExt":10,"email":10},{"facility":59,"status":10,"city":60,"state":10,"zip":10,"country":22,"countryCode":23,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Department of Pulmonology, Debrecen University","Debrecen",{"type":25,"coordinates":62},[63,64],21.62444,47.53167,{"lat":64,"lon":63},[67,68,70,72],{"name":32,"role":15,"phone":10,"phoneExt":10,"email":10},{"name":69,"role":35,"phone":10,"phoneExt":10,"email":10},"Krisztina Kukuly, Dr.",{"name":71,"role":35,"phone":10,"phoneExt":10,"email":10},"Tamás Kovács, Dr.",{"name":32,"role":39,"phone":10,"phoneExt":10,"email":10},{"facility":74,"status":10,"city":75,"state":10,"zip":10,"country":22,"countryCode":23,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Pulmonology Outpatient Clinic of Dunakeszi","Dunakeszi",{"type":25,"coordinates":77},[78,79],19.13864,47.63641,{"lat":79,"lon":78},[82,84],{"name":83,"role":15,"phone":10,"phoneExt":10,"email":10},"Katalin Kontz, Dr",{"name":85,"role":39,"phone":10,"phoneExt":10,"email":10},"Katalin Kontz, Dr.",{"facility":87,"status":10,"city":88,"state":10,"zip":10,"country":22,"countryCode":23,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Department of Pulmonology, University of Szeged","Szeged",{"type":25,"coordinates":90},[91,92],20.14824,46.253,{"lat":92,"lon":91},[95,97,99],{"name":96,"role":15,"phone":10,"phoneExt":10,"email":10},"Ádám Mihály",{"name":98,"role":39,"phone":10,"phoneExt":10,"email":10},"Ádám Mihály, Dr.",{"name":100,"role":35,"phone":10,"phoneExt":10,"email":10},"Dániel Vas, Dr.",{"facility":102,"status":10,"city":103,"state":10,"zip":10,"country":22,"countryCode":23,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Calvinist Pulmonology Centre","Törökbálint",{"type":25,"coordinates":105},[106,107],18.91356,47.42931,{"lat":107,"lon":106},[110,112,114,116,118],{"name":111,"role":15,"phone":10,"phoneExt":10,"email":10},"Alpár Horváth, Dr.",{"name":113,"role":39,"phone":10,"phoneExt":10,"email":10},"Alpár Horváth, Dr",{"name":115,"role":35,"phone":10,"phoneExt":10,"email":10},"Izolda Réti, Dr.",{"name":117,"role":35,"phone":10,"phoneExt":10,"email":10},"Botond Havadtői, Dr.",{"name":119,"role":35,"phone":10,"phoneExt":10,"email":10},"Norbert Ilyés, Dr.",{"type":121,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100580686","the-importance-of-tailored-education-and-device-handling-for-asthmatic-patients-100580686",false,"NCT06840522","The Importance of Tailored Education And Device Handling for Asthmatic Patients","TEACH","Inclusion Criteria:\n\n1. Physician-confirmed clinical diagnosis of asthma according to GINA guidelines\n2. Uncontrolled asthma according to the physician's clinical assessment despite the use of appropriate therapy of Step 2 or 3, according to GINA guidelines\n3. Patients who are eligible for the use of Foster Nexthaler 100\u002F6 mcg according to the SmPC\n4. Inhaled asthma therapy was changed independent from the study to Foster Nexthaler 100\u002F6 mcg DPI maximum 1 week prior to OR on the day of study inclusion\n5. Spirometry was performed as part of routine clinical practice\n6. Patient able to use their Foster Nexthaler device properly after education on inhaler technique\n7. Patient provided written, informed consent to study participation\n8. Patient ≥ 18 years of age\n\nExclusion Criteria:\n\n1. Participation in any clinical trial, 30 days prior to inclusion\n2. Patient is unable to execute a spirometry test\n3. Patients hospitalized due to an exacerbation of their asthma within the last 4 weeks prior to enrolment.\n4. Patients with other significant diseases of the respiratory system or other organ systems that may significantly contribute to asthma symptoms (such as severe heart failure, symptomatic anaemia, functional respiratory disorders, malignant diseases etc.) according to the physician's clinical assessment.\n5. Continuous use of oral corticosteroids (\\>5 mg prednisolone\u002Fday or \\>4 mg methylprednisolone\u002Fday)\n6. Use of continuous oxygen therapy\n7. Use of biologics for asthma treatment\n8. All exclusion criteria listed in Foster Nexthaler 100\u002F6 SmPC","ALL","18 Years",{"count":132,"type":133},250,"ESTIMATED","OBSERVATIONAL","Significant advancements have been made in asthma medication over the past decades. Highly effective treatments are available for patients; however, both adherence and proper device usage remain below the desired levels, based on our experience and literature data. Despite the availability of numerous excellent drug-device combinations, personalized treatment for patients is still not adequately addressed.\n\nIn the present study, the aim is to improve patient compliance and educate symptomatic, partially, or uncontrolled asthma patients on the correct use of a specific inhalation device (Nexthaler). Considering the characteristics of the medication, the patient's lung function data, inhalation technique, and drug retention time can help estimate the expected lung deposition of the medication. By refining the inhalation technique under the guidance of the treating physician, it is hypothesized that the expected therapeutic effects of the medication may improve.",[137],"Asthma",[139,140],"Inhalation treatment","Lung deposition","NOT_YET_RECRUITING","2025-02-21",{"date":144,"type":145},"2025-02-24","ACTUAL",{"date":147,"type":133},"2025-03-01",{"date":149,"type":133},"2026-08-01",{"name":5,"class":6},6]